The vaccine, called Ixchiq, is approved for people aged 18 and up who are at high risk of getting the disease. It was made by Valneva in Europe and is given in just one shot. A senior FDA official, Peter Marks, said chikungunya can cause serious illness and long-term health problems, especially for older adults and people with existing medical conditions. Since 2008, at least five million cases of chikungunya have been reported, with symptoms like rashes, headaches, and muscle pain. Joint pains can last for months or even years.

People in tropical and subtropical parts of Africa, Southeast Asia, and some areas of the Americas are at the highest risk of getting the disease because mosquitoes carrying the chikungunya virus are common there. But the FDA said the virus has spread to new places, leading to more cases worldwide. Brazil has reported the most cases this year, with 218,613, while India has reported over 93,000 cases, including a big outbreak in the capital, Delhi, in 2016.

Original news source: Chikungunya vaccine: US approves first shot against mosquito-borne virus (BBC)

– News Summary
Instructions: Students will be divided into small groups. Each group is tasked with summarizing the article in their own words, aiming for a concise summary of no more than four sentences. They should focus on the main points: the FDA approval, the impact of chikungunya, and the vaccine's global significance. Afterward, each group will present their summary to the class.
– Opinion Poll
Instructions: Create a list of statements about the chikungunya vaccine and its distribution, such as "The FDA's approval will significantly decrease the number of chikungunya cases globally." Students will walk around the room and poll their classmates, recording whether they agree or disagree with each statement. After polling, discuss the results as a class and examine the reasons behind the various opinions.
– Vocabulary Pictionary
Instructions: Write down key vocabulary from the article on slips of paper (e.g., vaccine, distribution, symptoms, tropical, subtropical, outbreak). Divide the class into two teams. Members take turns drawing a vocabulary word for their team to guess within a set time limit. The team with the most correct guesses wins.
– Speed Summarizing
Instructions: Pair up students and give them 3 minutes to discuss the article and then individually write a summary of the key points in just 60 seconds. After they finish, they will exchange their summaries with their partner to read and provide feedback on clarity and completeness.
– Future Predictions
Instructions: Students will individually write down their predictions about the future impact of the chikungunya vaccine based on the information in the article. They should consider questions like: How will the vaccine change the number of cases and deaths? Will it become widely available in all at-risk areas? After writing, students will share their predictions with a partner and discuss the likelihood and potential obstacles to their forecasts.

The US Food and Drug Administration has given the green ? to the first-ever vaccine for chikungunya, a disease spread by ?. Chikungunya causes fever and ? pains and can be deadly for newborns. The FDA's approval is expected to ? up the vaccine's distribution worldwide. This year, about 440,000 cases of chikungunya have been reported, with 350 deaths, and there's no specific medicine to treat it. ? America and South Asia have had the most cases this year. The vaccine, called ?, is approved for people aged 18 and up who are at high risk of getting the disease. It was made by Valneva in Europe and is given in just one shot. A ? FDA official, Peter Marks, said chikungunya can cause serious ? and long-term health problems, especially for older adults and ? with existing medical ?. Since 2008, at least five million cases of chikungunya have been reported, with symptoms like rashes, headaches, and muscle pain. Joint pains can last for ? or even years. People in tropical and subtropical parts of Africa, Southeast Asia, and some ? of the Americas are at the highest risk of getting the disease because mosquitoes carrying the chikungunya ? are ? there. But the FDA said the virus has ? to new places, leading to more cases worldwide. Brazil has reported the most cases this year, with 218,613, while India has reported over 93,000 cases, including a big ? in the capital, Delhi, in 2016.

1. What is a vaccine and why do you think it's important?
2. How would you feel if a new disease started spreading in your area?
3. Do you like the idea of getting vaccinated with just one shot? Why or why not?
4. Do you think vaccines should be required for everyone? Why or why not?
5. Have you or someone you know ever had a disease spread by mosquitoes? What was it like?
6. What do you think are the best ways to protect yourself from mosquito-borne diseases?
7. Why do you think newborns might be more at risk for diseases like chikungunya?
8. How do you think people in countries with lots of mosquitoes manage the risk of getting bitten?
9. Do you believe that vaccines can cause serious side effects? Why or why not?
10. What do you think about the fact that some diseases have no specific medicine to treat them?
11. Have you heard of chikungunya before reading this article? What was your first reaction to learning about it?
12. Why do you think the FDA's approval of a vaccine can speed up its distribution worldwide?
13. Do you think older adults and people with medical conditions should be more cautious about diseases like chikungunya? Why?
14. What are your thoughts on diseases that can cause long-term health problems, like joint pains that last for years?
15. How do you feel about the fact that viruses can spread to new places and affect more people?

Click a dot next to a word, then click the dot next to its meaning to draw a line connecting them.

Write a summary of this news article in two sentences.
Check your writing now with the best free AI for English writing!